Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Splenectomy in sickle cell disease.

B C Kar1

  • 1Medical Aid and Research Centre, Burla, Orissa.

The Journal of the Association of Physicians of India
|April 25, 2000
PubMed
Summary
This summary is machine-generated.

Splenectomy offers benefits for sickle cell disease patients, improving hemoglobin levels and reducing pain crises. This procedure is deemed acceptable for carefully selected individuals.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Clinical profile of sickle cell trait.

The Journal of the Association of Physicians of India·2003
Same author

Comparative evaluation of indirect and sandwich ELISA for the detection of antibodies to bovine respiratory syncytial virus (BRSV) in dairy cattle.

Comparative immunology, microbiology and infectious diseases·2002
Same author

Priapism is rare in sickle cell disease in India.

The Journal of the Association of Physicians of India·2001
Same author

Osmotic fragility of normal and sickle haemoglobin containing red blood cells.

Indian journal of physiology and pharmacology·1999
Same author

Cholelithiasis in sickle cell disease in India.

The Journal of the Association of Physicians of India·1997
Same author

Clinical profile of sickle cell disease in Orissa.

Indian journal of pediatrics·1997

Area of Science:

  • Hematology
  • Surgical Oncology

Background:

  • The role of splenectomy in sickle cell disease management remains debated.
  • This study investigates outcomes in 32 sickle cell disease patients who underwent splenectomy.

Purpose of the Study:

  • To evaluate the efficacy and safety of splenectomy in sickle cell disease.
  • To assess the impact of splenectomy on clinical outcomes and disease progression.

Main Methods:

  • Retrospective analysis of 32 sickle cell disease patients undergoing splenectomy.
  • Indications included acute splenic sequestration (53%), chronic hypersplenism (21.8%), splenic abscess, and frequent pain attacks.
  • Patients were observed for 2-3 years pre-splenectomy and followed for 1 to >8 years post-operatively.

Main Results:

Related Experiment Videos

  • Acute splenic sequestration resolved post-splenectomy.
  • In chronic hypersplenism and other cases, 81% experienced a >2 g/dL increase in steady-state hemoglobin.
  • Significant improvements in height (90%) and weight (61%) were observed.
  • 79% of patients showed reduced frequency of pain attacks, fever, anemia, and need for blood transfusions.

Conclusions:

  • Splenectomy is an acceptable surgical intervention for select sickle cell disease patients.
  • The procedure demonstrates significant benefits in improving hematological parameters and clinical well-being.